Key Takeaways
- •Rep. McCormick (R, GA-7) highlighted that over 400,000 studies may originate from fraudulent paper mills, while witnesses warned that foreign-owned publishers are tracking sensitive U.S. research data.
- •Jason Owen-Smith (Executive Director, Institute for Research on Innovation and Science) testified that major publishers track unpublished researcher data and may share it with IT offices in China.
- •Rep. Sykes (D, OH-13) pressed Carl Maxwell (Senior Vice President, Association of American Publishers) on how prohibiting federal funds for publishing fees would create an unfunded mandate for researchers.
- •Republicans focused on "publish or perish" incentives and CCP-linked fraud, while Democrats criticized administration budget cuts to research and warned against political interference in scientific integrity.
- •The committee will consider regulatory frameworks to treat research data as a strategic national asset and implement grant conditions that allow for funding termination over integrity violations.
Read the full transcript
Starting at $350/mo
- Full hearing transcripts
- Speaker timestamps with video verification
- Organization & competitor mentions
- Same-day delivery
- Personalized summaries
30-day money-back guarantee on all paid plans.
Hearing Analysis
Overview
This hearing examined the evolving landscape of scientific publishing, focusing on the systemic threats to research integrity and the shifting business models of major publishers. Members and witnesses addressed the proliferation of "paper mills," the rise of AI-generated fraudulent research, and the "publish or perish" culture that incentivizes quantity over rigorous validation. A significant portion of the discussion centered on the national security implications of large commercial publishers transitioning into data analytics companies, potentially exposing sensitive, pre-competitive American research data to foreign adversaries, specifically the People's Republic of China.
Key Testimony & Policy
The witnesses presented a multifaceted view of the publishing crisis. Mr. Carl Maxwell, Senior Vice President for Public Policy for the Association of American Publishers (AAP), defended the role of publishers in maintaining the "gold standard" of peer review but warned that federal mandates for immediate open access—specifically the 2022 Nelson Memo from the Office of Science and Technology Policy (OSTP)—create financial distortions. He argued that prohibiting federal funds from covering article processing charges (APCs) or subscription fees, as proposed in the President’s FY2027 budget, would create an "unfunded mandate" for researchers and cut off federal scientists from vital discovery tools.
Ms. Kate Travis, Managing Editor for Retraction Watch, provided data on the "industrial scale" of research fraud. She noted that while the global retraction rate is approximately 0.1%, China accounts for 42% of all retractions, compared to just 6% for the United States. She highlighted the $50 million Federal Trade Commission (FTC) judgment against OMICS International as a model for holding predatory publishers accountable. Travis called for greater transparency from federal oversight bodies, including the National Science Foundation (NSF) Office of Inspector General and the Office of Research Integrity (ORI), noting a decline in misconduct findings despite the rise in fraudulent activity.
Dr. Jason Owen-Smith, Executive Director of the Institute for Research on Innovation and Science (IRIS) at the University of Michigan, offered a stark warning regarding data security. He testified that major publishers like Elsevier are no longer just content providers but are now sophisticated data analytics firms. He specifically cited Elsevier’s 2022 acquisition of Interfolio, a platform used by hundreds of universities to manage hiring and tenure. Owen-Smith warned that this allows foreign-owned entities to track unpublished research statements and grant proposals, noting that Elsevier’s own privacy policy indicates data may be shared with offices in China.
Notable Exchanges & Partisan Dynamics
The hearing featured sharp partisan disagreements regarding the current administration's impact on science. Rep. Emilia Sykes (D, OH-13) and Rep. Suzanne Bonamici (D, OR-1) criticized the President’s budget for proposing significant cuts to the NSF and NASA, arguing these "sledgehammer" approaches undermine American competitiveness. Rep. Sykes highlighted OhioLINK as a successful state-level model for pooling purchasing power to reduce journal costs for institutions like Kent State University and the University of Akron.
Conversely, Chairman Richard McCormick (R, GA-7) and Rep. Brian Babin (R, TX-36) focused on the corruption of the scientific record by "junk science" and political interference. Chairman McCormick expressed concern that trillions of dollars in federal policy decisions, particularly regarding climate change, are being based on studies that are later retracted or found to be non-reproducible. Rep. Bill Foster (D, IL-11) raised concerns about political overreach, citing letters sent by a U.S. Attorney to journals like the New England Journal of Medicine and the Journal of the American Medical Association (JAMA) suggesting they were suppressing opposing viewpoints.
Ranking Member Zoe Lofgren (D, CA-18) bridged some of the divide by focusing on the "corrupt system" where taxpayers fund research, volunteers perform peer review, and then for-profit companies like Elsevier sell the results back to the public at massive profit margins. She advocated for a total rethink of the publishing cycle to prioritize data transparency over proprietary paywalls.
Organizations Mentioned
- Elsevier: Criticized for its transition into a data analytics firm and its acquisition of Interfolio, which may expose sensitive researcher data to foreign offices. - Association of American Publishers (AAP): Represented by Carl Maxwell, this group advocated for maintaining diverse business models and warned against federal bans on publishing fees. - Retraction Watch: Provided critical data on the rise of retractions and the prevalence of paper mills, particularly those originating in China. - National Science Foundation (NSF): Discussed regarding its role in investigating research misconduct and the impact of proposed budget cuts on its oversight capabilities. - Office of Research Integrity (ORI): Mentioned regarding the need for more transparent and frequent misconduct findings to police the scientific record. - OhioLINK: Praised as a model for state-funded consortia that save universities millions in journal subscription and publication fees. - Interfolio: Identified as a critical vulnerability in research security due to its collection of pre-competitive academic data under the ownership of Elsevier. - People's Republic of China (China): Frequently cited as the primary source of "paper mill" fraudulent research and a destination for sensitive American research data.
What's Next
The subcommittee indicated that the hearing record would remain open for 10 days for additional comments. Dr. Owen-Smith proposed a new regulatory framework that would treat data about federally funded research as a "strategic national asset," suggesting future legislative efforts may focus on creating public, accountable infrastructure for research data to replace proprietary systems. Members also signaled ongoing oversight of the OSTP’s implementation of open access policies and the potential impact of the FY2027 budget prohibitions on publishing fees.
Transcript
The Subcommittee on Investigations and Oversight will come to order. Without objection, the chair is authorized to declare recess of the subcommittee at any time. Welcome to today's hearing entitled, The State of Scientific Publishing: Assessing Trends, Emerging Issues, and Policy Considerations. I recognize myself for five minutes for an opening statement. Good morning and thank you for attending today. We are addressing a challenge that sits at the heart of the American scientific leadership, a challenge that demands honesty and scrutiny of the systems we rely on to produce and validate knowledge. Science advances through trust. Everything we do rests on the assumption that underlying work is real, rigorous, and honestly reported. I know the importance of this firsthand. From my time in medical school to practicing in the emergency room, my career has been based on published research and its credibility and its peer review process. Our actions are based on trust. Be it when a policymaker acts on published evidence or when a federal agency directs billions, if not trillions, of dollars in funding to specific research. That foundation is under threat. And it is the job of this committee to understand why. The scientific publishing ecosystem has changed dramatically. What was once a straightforward process of peer review and dissemination has become a complex, commercialized marketplace with maligned incentives and bad actors willing to exploit them. Now consider the scale of this problem. Estimates suggest over 400,000 published studies worldwide that may originate from so-called paper mills. Operations that produce fabricated and manipulated manuscripts for a fee. In 2023 alone, Wiley, a prominent American publisher, retracted over 8,000 fraudulent papers from a single subsidiary. This is not an anomaly. It's a symptom. The incentive structure driving this are well understood but underaddressed. Academic careers are built on publication counts. Institutions compete on research output. The result is a publish or perish culture that rewards quantity over quality and creates a ready market for shortcuts. When speed and quantity displace rigor or reproducibility, it is not just individual researchers who are harmed. It is the integrity of the science itself. Federal taxpayer dollars support the research that feeds this system. If fraudulent publications are being cited in grant applications that shape the direction of federal policy, American taxpayers will end up subsidizing corruption of the very science that they are paying to advance. Meanwhile, the Chinese Communist Party has built an academic incentive structure that has generated an industrial scale paper mill. Chinese universities have reportedly paid authors substantial cash rewards for publications in prestigious journals. A survey of medical residents at hospitals in Southwest China found that nearly half admitted, and that's just the people who admit, to buying papers, selling papers, or hiring ghostwriters to meet publication requirements. Critically, this fabricated research does not stay in China. It enters Western journals, shapes citations, and can contaminate the global scientific literature on which researchers depend. The rise of artificial intelligence intensifies all of this. AI lowers the cost of technical barriers to generate plausible looking scientific content at scale, even if it's inaccurate. The same tools that can accelerate legitimate research can be weaponized to fabricate data, manufacture citations, and flood the publication pipeline with content that appears credible but is not and is often referenced in other papers. As these capabilities grow, the gap between what looks like science and what actually science is will widen. Unless institutions, publishers, and federal agencies act deliberately to close that gap. Open access mandates, which this committee has engaged with extensively, add another layer of complexity. The movement to make federally funded research freely available is a worthy goal. But the article processing charge model used to make this financially feasible creates its own distortions. This model incentivizes publishers to prioritize quantity over quality, disadvantaging smaller institutions and enabling predatory journals that collect fees while providing no meaningful peer review. The agencies under this committee's jurisdiction have begun responding. Following letters sent by this committee earlier this year, agencies are developing awards conditions that can lead to suspension or termination of funding when integrity requirements are not met. That is a positive development and we want to understand how those efforts are progressing. But this agency action has limits and structural pressures faced by this industry require a more comprehensive response. This committee's responsibility to ensure that federal investments are science protected and that research enterprise maintains this credibility is required to function. And that American institutions are not disadvantaged by the competitors that treat scientific integrity as optional. That is the purpose of today's hearing. Our witnesses can help us understand both the depth and the problem of what meaningful solutions look like. To further support our understanding and discussion on this topic, I ask unanimous consent to include in this hearing record letters from the American Association of the Advancement of Science, the International Association of Scientific, Technical, and Medical Publishers, Wiley, Springer Nature, and the American Phytopathological Society, without objection, so ordered. Thank you and I look forward to a serious and substantive discussion. I now recognize Ranking Member, representative from Ohio, for opening statement.
Read the full transcript
Starting at $350/mo
- Full hearing transcripts
- Speaker timestamps with video verification
- Organization & competitor mentions
- Same-day delivery
- Personalized summaries
30-day money-back guarantee on all paid plans.
Not ready to subscribe?
Get a free daily digest with hearing summaries ranked by relevance.
Already have an account? Log in
